Google ARCH THERAPEUTICS REVIEW & ANALYSIS
Sentiment: Strong Buy
Get off the cactus. You were such a bull when not on it.
They have raised $ 12,990,669 since going public. Per Form 10-Q need $10 to $14 million for full human trials in Europe and USA. Plus they have warrants outstanding that will finance a lot of this. Oh..Management owns 25+ million including options
U still sitting on that cactus.....
They do not need to with all the warrants that have been exercised
Just watched the video on AC5. Thanks for sharing. Google this:
AC5 Surgical HemostatTM is an Effective Hemostatic Agent in Anticoagulated Animals